152 related articles for article (PubMed ID: 9211409)
1. Alpha-particle-emitting radioisotopes coupled to antibody for acute myeloid leukaemia treatment.
Featherstone C
Mol Med Today; 1997 Jun; 3(6):232-3. PubMed ID: 9211409
[No Abstract] [Full Text] [Related]
2. Clinical Studies with Bismuth-213 and Actinium-225 for Hematologic Malignancies.
Jurcic JG
Curr Radiopharm; 2018; 11(3):192-199. PubMed ID: 29793418
[TBL] [Abstract][Full Text] [Related]
3. Targeted alpha-particle immunotherapy for acute myeloid leukemia.
Jurcic JG; Rosenblat TL
Am Soc Clin Oncol Educ Book; 2014; ():e126-31. PubMed ID: 24857092
[TBL] [Abstract][Full Text] [Related]
4. Radioimmunotherapy with alpha-particle emitting radionuclides.
Zalutsky MR; Pozzi OR
Q J Nucl Med Mol Imaging; 2004 Dec; 48(4):289-96. PubMed ID: 15640792
[TBL] [Abstract][Full Text] [Related]
5. Sequential cytarabine and alpha-particle immunotherapy with bismuth-213-lintuzumab (HuM195) for acute myeloid leukemia.
Rosenblat TL; McDevitt MR; Mulford DA; Pandit-Taskar N; Divgi CR; Panageas KS; Heaney ML; Chanel S; Morgenstern A; Sgouros G; Larson SM; Scheinberg DA; Jurcic JG
Clin Cancer Res; 2010 Nov; 16(21):5303-11. PubMed ID: 20858843
[TBL] [Abstract][Full Text] [Related]
6. Targeted alpha particle immunotherapy for myeloid leukemia.
Jurcic JG; Larson SM; Sgouros G; McDevitt MR; Finn RD; Divgi CR; Ballangrud AM; Hamacher KA; Ma D; Humm JL; Brechbiel MW; Molinet R; Scheinberg DA
Blood; 2002 Aug; 100(4):1233-9. PubMed ID: 12149203
[TBL] [Abstract][Full Text] [Related]
7. Radioimmunotherapy with alpha-emitting nuclides.
McDevitt MR; Sgouros G; Finn RD; Humm JL; Jurcic JG; Larson SM; Scheinberg DA
Eur J Nucl Med; 1998 Sep; 25(9):1341-51. PubMed ID: 9724387
[TBL] [Abstract][Full Text] [Related]
8. [Alpha-radioimmunotherapy: a review of recent developments].
Supiot S; Thillays F; Rio E; Mahé MA; Barbet FJ; Kraeber-Bodéré F; Chérel M
Cancer Radiother; 2007 Sep; 11(5):252-9. PubMed ID: 17604673
[TBL] [Abstract][Full Text] [Related]
9. An Overview of Targeted Alpha Therapy with
Morgenstern A; Apostolidis C; Kratochwil C; Sathekge M; Krolicki L; Bruchertseifer F
Curr Radiopharm; 2018; 11(3):200-208. PubMed ID: 29732998
[TBL] [Abstract][Full Text] [Related]
10. Alpha-particle radioimmunotherapy with astatine-211 and bismuth-213.
Lucignani G
Eur J Nucl Med Mol Imaging; 2008 Sep; 35(9):1729-33. PubMed ID: 18542953
[No Abstract] [Full Text] [Related]
11. Development of Targeted Alpha Therapy from Bench to Bedside.
Morgenstern A; Bruchertseifer F
J Med Imaging Radiat Sci; 2019 Dec; 50(4S1):S18-S20. PubMed ID: 31405818
[TBL] [Abstract][Full Text] [Related]
12. Radionuclides for radioimmunotherapy: criteria for selection.
Geerlings MW
Int J Biol Markers; 1993; 8(3):180-6. PubMed ID: 8277210
[TBL] [Abstract][Full Text] [Related]
13. Targeted Alpha-Particle Therapy for Hematologic Malignancies.
Jurcic JG
J Med Imaging Radiat Sci; 2019 Dec; 50(4 Suppl 1):S53-S57. PubMed ID: 31253514
[TBL] [Abstract][Full Text] [Related]
14. Anti-CD33-antibodies labelled with the alpha-emitter Bismuth-213 kill CD33-positive acute myeloid leukaemia cells specifically by activation of caspases and break radio- and chemoresistance by inhibition of the anti-apoptotic proteins X-linked inhibitor of apoptosis protein and B-cell lymphoma-extra large.
Friesen C; Roscher M; Hormann I; Leib O; Marx S; Moreno J; Miltner E
Eur J Cancer; 2013 Jul; 49(11):2542-54. PubMed ID: 23684782
[TBL] [Abstract][Full Text] [Related]
15. Radioimmunotherapy with alpha-particle emitting radioimmunoconjugates.
Zalutsky MR; Bigner DD
Acta Oncol; 1996; 35(3):373-9. PubMed ID: 8679269
[TBL] [Abstract][Full Text] [Related]
16. Effective alpha-particle-mediated radioimmunotherapy of murine leukemia.
Huneke RB; Pippin CG; Squire RA; Brechbiel MW; Gansow OA; Strand M
Cancer Res; 1992 Oct; 52(20):5818-20. PubMed ID: 1394209
[TBL] [Abstract][Full Text] [Related]
17. An Appendix of Radionuclides Used in Targeted Alpha Therapy.
Ferrier MG; Radchenko V
J Med Imaging Radiat Sci; 2019 Dec; 50(4 Suppl 1):S58-S65. PubMed ID: 31427258
[No Abstract] [Full Text] [Related]
18. Modeling Cell and Tumor-Metastasis Dosimetry with the Particle and Heavy Ion Transport Code System (PHITS) Software for Targeted Alpha-Particle Radionuclide Therapy.
Lee D; Li M; Bednarz B; Schultz MK
Radiat Res; 2018 Sep; 190(3):236-247. PubMed ID: 29944461
[TBL] [Abstract][Full Text] [Related]
19. Rapid preparation of short-lived alpha particle emitting radioimmunopharmaceuticals.
Ma D; McDevitt MR; Finn RD; Scheinberg DA
Appl Radiat Isot; 2001 Oct; 55(4):463-70. PubMed ID: 11545498
[TBL] [Abstract][Full Text] [Related]
20. Radioimmunotherapy with α-particle-emitting radionuclides.
Seidl C
Immunotherapy; 2014; 6(4):431-58. PubMed ID: 24815783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
